How Peptides Are Used in Cancer Research
Learn how research peptides are used in cancer biology including IGF-1R research, somatostatin tumor targeting, immune modulation, peptide-drug conjugates, and cachexia research.
Foundational articles covering peptide science, amino acids, research concepts, laboratory terminology, and the basics of peptide research.
Learn how research peptides are used in cancer biology including IGF-1R research, somatostatin tumor targeting, immune modulation, peptide-drug conjugates, and cachexia research.
Complete peptide research glossary covering 50 essential terms across biochemistry, synthesis, analytical chemistry, pharmacology, and regulatory science for research peptide users.
Learn how oxidative stress and ROS biology connects to research peptides including SS-31, GHK-Cu, Epithalon, and how to measure antioxidant effects in research protocols.
Complete lab safety guide for peptide researchers covering PPE, sharps safety, contamination prevention, waste disposal, and emergency procedures for research peptide laboratories.
Learn how to set up a peptide research protocol covering research question definition, model selection, dosing parameters, control design, endpoint specification, and IACUC approvals.
Learn how to critically read and evaluate peptide research papers including methods assessment, sample size evaluation, control group design, and checking for independent replication.
Learn how peptide patents work including composition of matter vs method-of-use protection, patent duration, approved peptide IP status, natural sequence eligibility, and the research use exception.
Learn what pharmaceutical compounding is, the regulatory framework governing compounding pharmacies, how peptides intersect with compounding, and FDA regulatory actions affecting this space.
Learn the difference between in vitro and in vivo peptide research, the advantages and limitations of each, the translational hierarchy from cell culture to human studies, and ex vivo models.
Learn why most peptides are not orally bioavailable, the GI barriers they face, and strategies including cyclization, D-amino acids, SNAC, and nanoparticles that have achieved oral peptide delivery.